Evidence map›Paper›PMID 20072629›Full record

ArticlePloS one2010

The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.

Kristian Otkjaer, Helmut Holtmann, Tue Wenzel Kragstrup, Søren Riis Paludan, Claus Johansen, Matthias Gaestel, Knud Kragballe, Lars Iversen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. IL-24 intrinsically regulates Th17 cell pathogenicity in mice.The Journal of experimental medicine · 2022
    Article
  7. Review
  8. Article
  9. Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.American journal of physiology. Renal physiology · 2018
    Article
  10. Article
  11. Article
  12. Mechanism of Action and Applications of Interleukin 24 in Immunotherapy.International journal of molecular sciences · 2016
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. MDA-7/IL-24: multifunctional cancer killing cytokine.Advances in experimental medicine and biology · 2014
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kristian OtkjaerDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Helmut Holtmann
Tue Wenzel Kragstrup
Søren Riis Paludan
Claus Johansen
Matthias Gaestel
Knud Kragballe
Lars Iversen
Aarhus University Hospital · DKAarhus University · DKMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIL-24 (melanoma differentiation-associated gene-7 (mda-7)), a member of the IL-10 cytokine family, possesses the properties of a classical cytokine as well as tumor suppressor effects. The exact role of IL-24 in the immune system has not been defined but studies have indicated a role for IL-24 in inflammatory conditions such as psoriasis. The tumor suppressor effects of IL-24 include inhibition of angiogenesis, sensitization to chemotherapy, and p38 mitogen-activated protein kinase (MAPK)-mediated apoptosis. Current knowledge on the regulation of IL-24 expression is sparse. Previous studies have suggested that mRNA stabilization is of major importance to IL-24 expression. Yet, the mechanisms responsible for the regulation of IL-24 mRNA stability remain unidentified. As p38 MAPK is known to regulate gene expression by interfering with mRNA degradation we examined the role of p38 MAPK in the regulation of IL-24 gene expression in cultured normal human keratinocytes. METHODOLOGY/PRINCIPAL

findingsIn the present study we show that anisomycin- and IL-1beta- induced IL-24 expression is strongly dependent on p38 MAPK activation. Studies of IL-24 mRNA stability in anisomycin-treated keratinocytes reveal that the p38 MAPK inhibitor SB 202190 accelerates IL-24 mRNA decay suggesting p38 MAPK to regulate IL-24 expression by mRNA-stabilizing mechanisms. The insertion of the 3' untranslated region (UTR) of IL-24 mRNA in a tet-off reporter construct induces degradation of the reporter mRNA. The observed mRNA degradation is markedly reduced when a constitutively active mutant of MAPK kinase 6 (MKK6), which selectively activates p38 MAPK, is co-expressed. CONCLUSIONS/SIGNIFICANCE: Taken together, we here report p38 MAPK as a regulator of IL-24 expression and determine interference with destabilization mediated by the 3' UTR of IL-24 mRNA as mode of action. As discussed in the present work these findings have important implications for our understanding of IL-24 as a tumor suppressor protein as well as an immune modulating cytokine.

Indexed as

3' Untranslated RegionsAnisomycinCell LineEnzyme ActivationHumansImidazolesInterleukin-1betaInterleukin-24Interleukinsp38 Mitogen-Activated Protein KinasesProtein Kinase InhibitorsPyridinesRNA, Messenger3' Untranslated Regions4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazoleAnisomycinImidazolesInterleukin-1betaInterleukin-24Interleukinsp38 Mitogen-Activated Protein KinasesProtein Kinase InhibitorsPyridinesRNA, Messenger

Identifiers

PMID20072629
PMCPMC2801610
OpenAlexW2070804167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.